Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Natalie Lowry"'
Autor:
John Marsden, Mike Kelleher, Eilish Gilvarry, Luke Mitcheson, Jatinder Bisla, Angela Cape, Fiona Cowden, Edward Day, Jonathan Dewhurst, Rachel Evans, Will Hardy, Andrea Hearn, Joanna Kelly, Natalie Lowry, Martin McCusker, Caroline Murphy, Robert Murray, Tracey Myton, Sophie Quarshie, Rob Vanderwaal, April Wareham, Dyfrig Hughes, Zoë Hoare
Publikováno v:
EClinicalMedicine, Vol 66, Iss , Pp 102311- (2023)
Summary: Background: Daily methadone maintenance or buprenorphine treatment is the standard-of-care (SoC) medication for opioid use disorder (OUD). Subcutaneously injected, extended-release buprenorphine (BUP-XR) may be more effective—but there has
Externí odkaz:
https://doaj.org/article/74984ad835324f68b7da701787e3a009
Autor:
John Marsden, Mike Kelleher, Zoë Hoare, Dyfrig Hughes, Jatinder Bisla, Angela Cape, Fiona Cowden, Edward Day, Jonathan Dewhurst, Rachel Evans, Andrea Hearn, Joanna Kelly, Natalie Lowry, Martin McCusker, Caroline Murphy, Robert Murray, Tracey Myton, Sophie Quarshie, Gemma Scott, Sophie Turner, Rob Vanderwaal, April Wareham, Eilish Gilvarry, Luke Mitcheson
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-19 (2022)
Abstract Background Sublingual tablet buprenorphine (BUP-SL) and oral liquid methadone (MET) are the daily, standard-of-care (SOC) opioid agonist treatment medications for opioid use disorder (OUD). A sizable proportion of the OUD treatment populatio
Externí odkaz:
https://doaj.org/article/c1de5f4dc8184921b4e125d09f8a1f10
Autor:
Luke Mitcheson, John Marsden, Natalie Lowry, Mike Kelleher, Gemma Scott, Sophie Turner, Annette Hodge, Waniya Ashraf, Katie McClean
Publikováno v:
BMJ Open, Vol 13, Iss 3 (2023)
Objectives During the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) medication flexibly. With the aim for most patien
Externí odkaz:
https://doaj.org/article/07add96d69fb4819ba02cd342aaf3196
Autor:
Eilish Gilvarry, Luke Mitcheson, Edward Day, John Marsden, Natalie Lowry, Fiona Cowden, Stacey Johnstone, Robbie Murray, Mike Kelleher
Publikováno v:
BMJ Open, Vol 12, Iss 10 (2022)
Introduction Opioid use disorder (OUD) is a debilitating and persistent disorder. The standard-of-care treatment is daily maintenance dosing of sublingual buprenorphine (BUP-SL) or oral methadone (MET). Monthly, extended-release, subcutaneous injecta
Externí odkaz:
https://doaj.org/article/9fc6ae523fc247d1b3abc69316411e11
Autor:
Natalie Lowry, Santiago Peralta
Publikováno v:
Journal of the American Veterinary Medical Association.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ee473f26c4b72584ee087e9c3365e63
https://pubmed.ncbi.nlm.nih.gov/35905153
https://pubmed.ncbi.nlm.nih.gov/35905153
Autor:
Gemma Scott, Sophie Turner, Natalie Lowry, Annette Hodge, Waniya Ashraf, Katie McClean, Mike Kelleher, Luke Mitcheson, John Marsden
Publikováno v:
BMJ Open. 13:e069857
ObjectivesDuring the COVID-19 pandemic, addiction treatment services received official guidance asking them to limit face-to-face contact with patients and to prescribe opioid agonist treatment (OAT) medication flexibly. With the aim for most patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa758417080188b06fe875c2b9e022ea
https://doi.org/10.1136/bmjopen-2022-069857
https://doi.org/10.1136/bmjopen-2022-069857
Autor:
John Marsden, Mike Kelleher, Zoë Hoare, Dyfrig Hughes, Jatiner Bisla, Angela Cape, Fiona Cowden, Ed Day, Jonathan Dewhurst, Rachel Evans, Andrea Hearn, Joanna Kelly, Natalie Lowry, Martin McCusker, Caroline Murphy, Robert Murray, Tracy Myton, Sophie Quarshie, Gemma Scott, Sophie Turner, Rob Vanderwaal, April Wareham, Eilish Gilvarry, Luke Mitcheson
BACKGROUND: Sublingual buprenorphine (BUP-SL) and liquid methadone (MET) and are the standard-of-care (SOC), daily maintenance medications for the treatment of opioid use disorder (OUD). A sizable proportion of the OUD treatment population does not a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8d59b46fc1d4bbef6fa2a8e438bb3a6
https://doi.org/10.21203/rs.3.rs-1030868/v1
https://doi.org/10.21203/rs.3.rs-1030868/v1
Autor:
Natalie Lowry, Fiona Cowden, Edward Day, Eilish Gilvarry, Stacey Johnstone, Robbie Murray, Mike Kelleher, Luke Mitcheson, John Marsden
Publikováno v:
BMJ Open. 12:e067194
IntroductionOpioid use disorder (OUD) is a debilitating and persistent disorder. The standard-of-care treatment is daily maintenance dosing of sublingual buprenorphine (BUP-SL) or oral methadone (MET). Monthly, extended-release, subcutaneous injectab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87d734fe6932b01312e3712749aaaead
https://doi.org/10.1136/bmjopen-2022-067194
https://doi.org/10.1136/bmjopen-2022-067194